Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David E Root

Showing results (181-190 of 200) with videos related to

Pageof 20
Sort By:
Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.
Nature Immunology|September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancerJuan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.
Nature|November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M Johannessen, Jesse S Boehm, So Young Kim, et al.
The New England Journal of Medicine|June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in CancerMark M Awad, Shengwu Liu, Igor I Rybkin, et al.
Cell Systems|October 10, 2017
A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell LinesMehmet Gönen, Barbara A Weir, Glenn S Cowley, et al.
Scientific Data|May 19, 2015
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependenciesGlenn S Cowley, Barbara A Weir, Francisca Vazquez, et al.
Nature Biotechnology|September 11, 2010
Towards patient-based cancer therapeutics, Stuart L Schreiber, Alykhan F Shamji, et al.
Nature|April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancersEdmond M Chan, Tsukasa Shibue, James M McFarland, et al.
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Cancer Discovery|May 30, 2013
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancerYan Liu, Kevin Marks, Glenn S Cowley, et al.
Pageof 20

Showing results (181-190 of 200) with videos related to

Sort By:
Pageof 20
Cancer Cell|July 4, 2009
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancerKrishna M Vasudevan, David A Barbie, Michael A Davies, et al.
Nature Immunology|September 23, 2022
In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancerJuan Dubrot, Peter P Du, Sarah Kate Lane-Reticker, et al.
Nature|November 26, 2010
COT drives resistance to RAF inhibition through MAP kinase pathway reactivationCory M Johannessen, Jesse S Boehm, So Young Kim, et al.
The New England Journal of Medicine|June 23, 2021
Acquired Resistance to KRAS<sup>G12C</sup> Inhibition in CancerMark M Awad, Shengwu Liu, Igor I Rybkin, et al.
Cell Systems|October 10, 2017
A Community Challenge for Inferring Genetic Predictors of Gene Essentialities through Analysis of a Functional Screen of Cancer Cell LinesMehmet Gönen, Barbara A Weir, Glenn S Cowley, et al.
Scientific Data|May 19, 2015
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependenciesGlenn S Cowley, Barbara A Weir, Francisca Vazquez, et al.
Nature Biotechnology|September 11, 2010
Towards patient-based cancer therapeutics, Stuart L Schreiber, Alykhan F Shamji, et al.
Nature|April 12, 2019
WRN helicase is a synthetic lethal target in microsatellite unstable cancersEdmond M Chan, Tsukasa Shibue, James M McFarland, et al.
Communications Biology|April 8, 2024
Targeting TRIP13 in favorable histology Wilms tumor with nuclear export inhibitors synergizes with doxorubicinKaruna Mittal, Garrett W Cooper, Benjamin P Lee, et al.
Cancer Discovery|May 30, 2013
Metabolic and functional genomic studies identify deoxythymidylate kinase as a target in LKB1-mutant lung cancerYan Liu, Kevin Marks, Glenn S Cowley, et al.
Pageof 20